Clinical trials
Phase 1 Skin Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Recruiting | 12 |
| Active, not recruiting | 9 |
| Terminated | 9 |
| Unknown status | 5 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 8 |
| Case Comprehensive Cancer Center | 2 |
| Immorna Biotherapeutics, Inc. | 2 |
| Massachusetts General Hospital | 2 |
| National Cancer Institute (NCI) | 2 |
| Novartis Pharmaceuticals | 2 |
| Revolution Medicines, Inc. | 2 |
| Roswell Park Cancer Institute | 2 |
| Al-Azhar University | 1 |
| Ankyra Therapeutics, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Skin Neoplasms | 69 |
| Melanoma | 27 |
| Neoplasms | 17 |
| Lung Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Head and Neck Neoplasms | 13 |
| Basal Cell Carcinoma | 12 |
| Breast Neoplasms | 12 |
| Cutaneous Squamous Cell Carcinoma | 9 |
| Neoplasm Metastasis | 8 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.